Nasdaq: XCUR/Biotechnology
Exicure, Inc.
Redwood City, CA, United States
Company overview
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.